Drugs / bone marrow aspirate concentrate
bone marrow aspirate concentrate
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| — | NCT04222140 Comparator | Aug 2020 → Aug 2021 | osteoarthritis, knee | Affinity Health Research Institute | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | bone marrow aspirate concentrate | “The ERIPTO study seeks to study a proposed protocol utilizing various components of regenerative medicine including platelet rich plasma (PRP), hyaluronic acid (HA), and human...” NCT04222140 ↗ |
| Known as | BMAC | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04222140 ↗ |
| Known as | human bone marrow aspirate concentrate | “The ERIPTO study seeks to study a proposed protocol utilizing various components of regenerative medicine including platelet rich plasma (PRP), hyaluronic acid (HA), and human...” NCT04222140 ↗ |